IL-22: A critical mediator in mucosal host defense (original) (raw)

Abstract

IL-22 is an IL-10 family cytokine member that was recently discovered to be produced by Th17 cells. Current studies have revealed that IL-22 targets cells of the digestive, skin, and respiratory organ systems and plays an important role in mucosal immunity. The IL-22 receptor (IL-22R) is expressed exclusively in these tissues, thereby allowing the cytokine to mediate epithelial innate immunity in response to a variety of pathogens. Although recent studies have shown the importance of IL-22 in host defense against Gram-negative bacterial organisms (in gut and lung), there is evidence that IL-22 also plays a role in autoimmune disease, such as psoriasis. IL-22 therefore, not unlike other cytokines, has complex pro-inflammatory, anti-inflammatory, and autoimmune effects which continue to be under further investigation. This review will focus on what is known about IL-22 and its function in mucosal host defense.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Dumoutier et al (2000) Cloning and characterization of IL-10-related T cell derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164:1814–1819
    CAS PubMed Google Scholar
  2. Wolk K, Sabat R (2006) Interleukin-22: a novel T and NK cell-derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17:367–380
    Article CAS PubMed Google Scholar
  3. Wolk X et al (2004) IL-22 increases the innate immunity of tissues. Immun 21:241–254
    Article CAS Google Scholar
  4. Wynn T (2005) Th17: a giant step from Th1 and Th2. Nat Immunol 6:1069–1070
    Article CAS PubMed Google Scholar
  5. Betteli X et al (2007) Th17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350
    Article Google Scholar
  6. Liang X et al (2006) Interleukin 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279
    Article CAS PubMed Google Scholar
  7. Boniface X et al (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174:3695–3702
    CAS PubMed Google Scholar
  8. Wolk X et al (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36:1309–1323
    Article CAS PubMed Google Scholar
  9. Ma X et al (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597–607
    CAS PubMed Google Scholar
  10. Caproni X et al (2008) Serum levels of IL-17 and IL-22 are reduced by Etanercept, but not by Acitretin, in patients with psoriasis: a randomized controlled trial. J Clin Immunol. doi:10.1007/s10875-008-9233-0
  11. Nagalakshmi X et al (2004) Interleukin 22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 4:679–691
    Article CAS PubMed Google Scholar
  12. Brand X et al (2006) IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290:G827–G838
    Article CAS PubMed Google Scholar
  13. Sugimoto X et al (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534–544
    CAS PubMed Google Scholar
  14. Zheng X et al (2008) Interleukin 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289
    Article CAS PubMed Google Scholar
  15. Whittington X et al (2004) IL-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol 31:220–226
    Article CAS PubMed Google Scholar
  16. Aujla X et al (2008) IL-22 mediates mucosal host defense against gram negative bacterial pneumonia. Nat Med 14:275–281
    Article CAS PubMed Google Scholar
  17. Andoh X et al (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterol 129:969–984
    Article CAS Google Scholar
  18. Cella X et al (2008) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nat: Epub ahead of print
  19. Wolk X et al (2007) IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn’s disease. J Immunol 178:5973–5981
    CAS PubMed Google Scholar
  20. Zheng X et al (2007) Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nat 445:648–651
    Article CAS Google Scholar
  21. Malmberg K, Ljunggren H (2009) Spotlight on IL-22-producing NK cell receptor expressing mucosal lymphocytes. Nat Immunol 10:11–12
    Article CAS PubMed Google Scholar
  22. Sanos X et al (2009) RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10:83–91
    Article CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary Medicine, Allergy and Immunology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
    S. J. Aujla & J. K. Kolls

Authors

  1. S. J. Aujla
  2. J. K. Kolls

Corresponding author

Correspondence toS. J. Aujla.

Rights and permissions

About this article

Cite this article

Aujla, S.J., Kolls, J.K. IL-22: A critical mediator in mucosal host defense.J Mol Med 87, 451–454 (2009). https://doi.org/10.1007/s00109-009-0448-1

Download citation

Keywords